Centogene Pre-Tax Profit Margin 2019-2023 | CNTG

Centogene pre-tax profit margin from 2019 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Centogene Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2022-06-30 $0.11B $-0.06B -59.26%
2022-03-31 $0.16B $-0.06B -39.24%
2021-12-31 $0.22B $-0.06B -25.00%
2021-09-30 $0.26B $-0.04B -14.84%
2021-06-30 $0.26B $-0.02B -7.25%
2021-03-31 $0.21B $-0.02B -9.48%
2020-12-31 $0.15B $-0.02B -15.75%
2020-09-30 $0.08B $-0.03B -39.24%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.000B $0.050B
Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.527B 19.51
Inspire Medical Systems (INSP) United States $7.610B 0.00
IRhythm Technologies (IRTC) United States $3.451B 0.00
Axonics (AXNX) United States $3.424B 0.00
10x Genomics (TXG) United States $3.133B 0.00
Azenta (AZTA) United States $2.932B 238.96
Olink Holding AB (publ) (OLK) Sweden $2.862B 0.00
Enovis (ENOV) United States $2.859B 21.19
Hims & Hers Health (HIMS) United States $2.622B 0.00
Privia Health (PRVA) United States $2.184B 96.89
Schrodinger (SDGR) United States $1.677B 0.00
Omnicell (OMCL) United States $1.345B 46.49
Phreesia (PHR) United States $1.255B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Standard BioTools (LAB) United States $0.734B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.701B 0.00
Fulgent Genetics (FLGT) United States $0.635B 0.00
Talkspace (TALK) United States $0.531B 0.00
Health Catalyst (HCAT) United States $0.386B 0.00
Pulmonx (LUNG) United States $0.361B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.331B 0.00
Clover Health Investments (CLOV) United States $0.319B 0.00
Butterfly Network (BFLY) United States $0.192B 0.00
P3 Health Partners (PIII) United States $0.189B 0.00
Outset Medical (OM) United States $0.155B 0.00
American Well (AMWL) United States $0.151B 0.00
Augmedix (AUGX) United States $0.130B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
TruBridge (TBRG) United States $0.125B 5.32
111 (YI) China $0.094B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
NantHealth (NHIQ) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.056B 0.00
Movano (MOVE) United States $0.050B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00